Thomas F. Parsons
Millennium Pharmaceuticals
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Thomas F. Parsons.
Journal of Biological Chemistry | 2002
Chad Vickers; Paul Hales; Virendar Kaushik; Larry Dick; James M. Gavin; Jin Tang; Kevin Godbout; Thomas F. Parsons; Elizabeth Baronas; Frank Y. Hsieh; Susan Acton; Michael A. Patane; Andrew Nichols; Peter J. Tummino
Human angiotensin-converting enzyme-related carboxypeptidase (ACE2) is a zinc metalloprotease whose closest homolog is angiotensin I-converting enzyme. To begin to elucidate the physiological role of ACE2, ACE2 was purified, and its catalytic activity was characterized. ACE2 proteolytic activity has a pH optimum of 6.5 and is enhanced by monovalent anions, which is consistent with the activity of ACE. ACE2 activity is increased ∼10-fold by Cl− and F− but is unaffected by Br−. ACE2 was screened for hydrolytic activity against a panel of 126 biological peptides, using liquid chromatography-mass spectrometry detection. Eleven of the peptides were hydrolyzed by ACE2, and in each case, the proteolytic activity resulted in removal of the C-terminal residue only. ACE2 hydrolyzes three of the peptides with high catalytic efficiency: angiotensin II (1-8) (k cat/K m = 1.9 × 106 m −1 s−1), apelin-13 (k cat/K m = 2.1 × 106 m −1s−1), and dynorphin A 1–13 (k cat/K m = 3.1 × 106 m −1 s−1). The ACE2 catalytic efficiency is 400-fold higher with angiotensin II (1-8) as a substrate than with angiotensin I (1-10). ACE2 also efficiently hydrolyzes des-Arg9-bradykinin (k cat/K m = 1.3 × 105 m −1 s−1), but it does not hydrolyze bradykinin. An alignment of the ACE2 peptide substrates reveals a consensus sequence of: Pro-X (1–3 residues)-Pro-Hydrophobic, where hydrolysis occurs between proline and the hydrophobic amino acid.
Molecular Microbiology | 2006
Gang Lin; Guiqing Hu; Christopher Tsu; Yune Z. Kunes; Huilin Li; Lawrence Dick; Thomas F. Parsons; Ping Li; Zhiqiang Chen; Peter Zwickl; Nadine S. Weich; Carl Nathan
Genes predicted to be associated with the putative proteasome of Mycobacterium tuberculosis (Mtb) play a critical role in defence of the bacillus against nitrosative stress. However, proteasomes are uncommon in eubacteria and it remains to be established whether Mtbs prcBA genes in fact encode a proteasome. We found that coexpression of recombinant PrcB and PrcA in Escherichia coli over a prolonged period at 37°C allowed formation of an α7β7β7α7, 750u2003kDa cylindrical stack of four rings in which all 14 β‐subunits were proteolytically processed to expose the active site threonine. In contrast to another Actinomycete, Rhodococcus erythropolis, Mtbs β‐chain propeptide was not required for particle assembly. Peptidolytic activity of the 750u2003kDa particle towards a hydrophobic oligopeptide was nearly two orders of magnitude less than that of the Rhodococcus 20S proteasome, and unlike eukaryotic and archaeal proteasomes, activity of the Mtb 750u2003kDa particle could not be stimulated by SDS, Mg2+ or Ca2+. Electron microscopy revealed what appeared to be obstructed α‐rings in the Mtb 750u2003kDa particle. Deletion of the N‐terminal octapeptide from Mtbs α‐chain led to disappearance of the apparent obstruction and a marked increase of peptidolytic activity. Unlike proteasomes isolated from other Actinomycetes, the open‐gate Mtb mutant 750u2003kDa particle cleaved oligopeptides not only after hydrophobic residues but also after basic, acidic and small, neutral amino acids. Thus, Mtb encodes a broadly active, gated proteasome that may work in concert with an endogenous activator.
Methods in Enzymology | 1985
Thomas F. Parsons; Thomas W. Strickland; John G. Pierce
Publisher Summary One group of polypeptide hormones, the glycoprotein hormones of the anterior pituitary and the placenta and related tissues, exhibits features otherwise not found in the large number of polypeptides now recognized to have hormonal activities. These hormones, luteinizing hormone (LH), thyroid-stimulating hormone (TSH), follicle-stimulating hormone (FSH), and chorionic gonadotropin consist of two distinct peptide chains, both rich in intra chain disulfides and both glycosylated. One chain or subunit (α) has, within a species, essentially the same amino acid sequence from hormone to hormone; the other subunits (β), while probably evolving from a single primitive gene, have different sequences. These sequences, when correctly folded, must contain the information, which upon combination with α subunit, gives rise to a specific hormone activity. The interaction between the two subunits is solely via non-covalent forces, and the formation of a hormonally active α–β dimer is accompanied by changes in conformation of both subunits. In the future, high-performance liquid chromatography shows the most promise for rapid and easy separation of subunits and some initial results.
Assay and Drug Development Technologies | 2003
Michael E. Bembenek; Sadhana Jain; Andrea Prack; Ping Li; Linda Chee; Wei Cao; Heidi Spurling; Rebecca Roy; Susan M. Fish; Mihail Rokas; Thomas F. Parsons; Rachel Meyers
Inositol-specific PLCs comprise a family of enzymes that utilize phosphoinositide substrates, e.g., PIP(2), to generate intracellular second messengers for the regulation of cellular responses. In the past, monitoring this reaction has been difficult due to the need for radiolabeled substrates, separation of the reaction products by organic-phase extraction, and finally radiometric measurements of the segregated products. In this report, we have studied the enzymatic characteristics of two novel PLCs that were derived from functional genomic analyses using a phospholipid-modified solid scintillating support. This method allows for the hydrophobic capture of the [(3)H]phosphoinositide substrate on a well defined scintillation surface and the homogenous measurement of the enzymatic hydrolysis of the substrate by proximity effects. Our results show that the assay format is robust and well suited for this class of lipid-metabolizing enzymes.
Assay and Drug Development Technologies | 2004
Michael E. Bembenek; Rebecca Roy; Ping Li; Linda Chee; Sadhana Jain; Thomas F. Parsons
Fatty acyl coenzyme A (CoA) synthetases are a group of enzymes responsible for the activation of fatty acids through ligated high-energy CoA thioester bonds. Ultimately these fatty acyl-CoA conjugates are routed toward either anabolic or catabolic pathways. Long-chain-fatty-acid-CoA ligase 5 (LACS 5) utilizes a wide range of saturated fatty acids with a substrate preference for C16-C18 unsaturated fatty acids. This enzyme represents a new class of potential drug targets, and, hence, our efforts were focused upon developing a robust assay for utilization in a high throughput screen. Toward that end, we describe a radiometric homogeneous measurement of the enzymatic reaction by employing ionic capture of the reaction product onto YSi scintillation proximity assay (SPA) beads. We present kinetic and inhibition data for LACS 5 using this SPA format. Our results show that the assay method is both robust and well suited for this class of lipid-metabolizing enzymes.
Assay and Drug Development Technologies | 2003
Michael E. Bembenek; Stephen Schmidt; Ping Li; Jennifer Morawiak; Andrea Prack; Sadhana Jain; Rebecca Roy; Thomas F. Parsons; Linda Chee
We have characterized a recombinantly expressed N-terminally tagged GST fusion of the tyrosine kinase domain of human EphB3. The EphB3 kinase domain was shown to phosphorylate a group of synthetic tyrosine-containing peptides derived from a proprietary biotinylated kinase-biased peptide substrate library. In addition, the enzyme activity was stimulated by the divalent cation, manganese, and inhibited by addition of magnesium. The most active tyrosine-containing peptide, a biotinylated 49-mer, displayed saturation kinetics with an apparent K(m) of approximately 0.4 microM. The apparent K(m) for ATP was determined to be approximately 3 microM. The kinetics of the reaction was linear from concentrations of enzyme of 0.5 to 2 nM, and at or below the K(m) concentrations of the two substrates for at least 2 h at room temperature. Moreover, the tryrosine kinase inhibitor, PP2, produced an IC(50) of roughly 0.8 microM. In addition, the enzyme tolerated the solvent DMSO and was stable to multiple freeze/thaw cycles. Stability of the enzyme at 4 degrees C storage was seen out to 6 h with an approximately 50% reduction of activity by 24 h. Formatting the assay in a 384-well microtiter plate produced good uniformity of signal at 100% inhibition, 50% inhibition, and no inhibition. The coefficient of variance was at or below 10% with a signal-to-background ratio of approximately 24 and a z value of 0.72. Collectively, these results showed the ability to configure a robust HTS for a truncated recombinantly expressed family member of the Ephrin tyrosine kinases.
Journal of Biological Chemistry | 2004
Paul Towler; Bart L. Staker; Sridhar G. Prasad; Saurabh Menon; Jin Tang; Thomas F. Parsons; Dominic Ryan; Martin Fisher; David A. Williams; Natalie A. Dales; Michael A. Patane; Michael W. Pantoliano
Journal of Biological Chemistry | 1983
Thomas F. Parsons; G A Bloomfield; John G. Pierce
Journal of Biological Chemistry | 1978
Thomas F. Parsons; Jack Preiss
Journal of Biological Chemistry | 1972
Michael N. Blackburn; John M. Chirgwin; Gordon T. James; Thomas D. Kempe; Thomas F. Parsons; Adele M. Register; Klaus D. Schnackerz; Ernst A. Noltmann